triflupromazine has been researched along with monensin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CL; Hou, WH; Hsiao, G; Huang, JS; Huang, SS; Liu, IH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for triflupromazine and monensin
| Article | Year |
|---|---|
Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses.
Topics: Animals; Apolipoproteins E; beta-Cyclodextrins; Cadaverine; Carrier Proteins; Cell Line; Clathrin; Endocytosis; Enzyme Inhibitors; Female; GTP-Binding Proteins; Hydrazones; Mice; Mice, Inbred C57BL; Mice, Knockout; Monensin; Plasminogen Activator Inhibitor 1; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Triflupromazine | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |